| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82ca46f9faf8903b8e3259953f96d624
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6d7fdb5a15c7530bb98f2cce5027261
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f15120bb60ad3f1fec490455c86bd87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2c2459d9831616925869af1a2de323e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef67d2044eaad25f8618a5cbc480eec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2002-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5320dfe10bc521083137c7c1a2bf98a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3c95711c6d08faaa5dd5181d035d804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a293ac1c0bcac8f2ffdd4b4454505147
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f17be181a3086a78be5c5a8c67faeb |
| publicationDate |
2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03040693-A2 |
| titleOfInvention |
Peptides that home to tumor lymphatic vasculature and methods of using same |
| abstract |
The present invention provides a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature. The invention also provides a method of directing a moiety to tumor lymphatic vasculature in a subject by administering to the subject a conjugate containing a moiety linked to a homing molecule that selectively homes to tumor lymphatic vasculature. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012165269-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1796707-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008512391-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008100328-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8906355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10669311-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8536132-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8178104-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013156723-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011127405-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8637635-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1996607-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877889-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1996607-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7919466-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11512110-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1796707-A4 |
| priorityDate |
2001-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |